Kuro Games announced the events and banners for Wuthering Waves version 2.3 Phase 2 (Image via Kuro Games) Kuro Games announced all the events and banners coming with Wuthering Waves 2.3 second phase.

while AI Ultra — priced at $249 per month — grants higher usage limits and early access to Veo 3 with native audio generation. AI 3D Generators are powerful tools for many different industries.

This makes a portable home generator a popular piece of gear to keep on hand, but connecting one to the house takes a bit of know-how and planning. There are three ways you can safely deliver ...

Google on Tuesday announced Veo 3, an AI video generator that can also create and incorporate audio. The artificial intelligence tool competes with OpenAI's Sora video generator, but its ability ...

Google’s latest video-generating AI model, Veo 3, can create audio to go along with the clips that it generates. On Tuesday during the Google I/O 2025 developer conference, Google unveiled Veo 3 ...

The proposed agreement is being structured in three tranches, with the first phase likely to include improved market access for U.S. industrial goods, selected agricultural products, and the ...

Now, Merck has offered up data from the successful first cohort to justify its intention to push the enpatoran program into phase 3. Specifically, enpatoran demonstrated a clinically meaningful ...

Google announced Veo 3 just days ago, and the internet is officially obsessed! The company’s latest AI video generator has gone viral for all the right (and sometimes unsettling) reasons.

The update also includes new AI-powered features for Paint like a sticker generator, and improvements to the Snipping Tool that can automatically crop and resize screenshots based on what you’re ...

Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol a ...

The full result from Eisai’s large, global phase 3 confirmatory Clarity AD clinical study of lecanemab – an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of ...